TTC7A inhibitors are a class of chemical compounds that specifically target and inhibit the function of the Tetratricopeptide Repeat Domain 7A (TTC7A) protein. TTC7A is part of a family of proteins characterized by tetratricopeptide repeat (TPR) motifs, which are involved in mediating protein-protein interactions. TTC7A is known to play a critical role in regulating cellular functions such as protein trafficking, membrane dynamics, and cell structure maintenance, particularly in epithelial cells. This protein is involved in coordinating the assembly of complex protein networks that regulate cell polarization, adhesion, and signal transduction pathways. By inhibiting TTC7A, these compounds disrupt its ability to form necessary interactions, leading to changes in cellular organization and signaling processes.
Structurally, TTC7A inhibitors are designed to bind to the TPR domains or other critical regions of the protein that are essential for its interaction with other cellular proteins. By blocking these interactions, the inhibitors prevent TTC7A from carrying out its regulatory roles in cellular processes such as maintaining the integrity of the plasma membrane and organizing cytoskeletal elements. This inhibition provides researchers with tools to study the specific contributions of TTC7A to cellular homeostasis, particularly in the context of epithelial tissue dynamics. By altering TTC7A activity, researchers can investigate how this protein influences key processes like protein trafficking, membrane stability, and the organization of cellular junctions. Understanding the role of TTC7A through inhibition sheds light on the broader mechanisms of cell structure and function, particularly in tissues that rely on precise regulation of membrane dynamics and protein interactions.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits protein synthesis, which may reduce TTC7A levels. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interferes with transcription, potentially lowering TTC7A mRNA levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
By inhibiting mTOR, it might affect protein synthesis, including TTC7A. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Tyrosine kinase inhibitor that might affect signaling pathways regulating TTC7A expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that might influence pathways involved in TTC7A regulation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MAPK, potentially affecting pathways that regulate TTC7A expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that might modify stress-related pathways affecting TTC7A expression. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor, potentially affecting inflammatory responses that could modulate TTC7A expression. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor that might affect multiple pathways, possibly including those regulating TTC7A. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibitor of ROCK, might influence cytoskeletal organization and pathways related to TTC7A. | ||||||